Significance of the adrenergic system in the regulation of vasopressin secretion in rat neurohypophyseal tissue cultures

Regulatory Peptides

Volumn 148, Issue 1-3, 2008, Pages 1-5

  Radacs M ^a   Galfi M ^a   Nagyeri Gy ^a   Molnar A H ^a   Varga, Cs ^a   Laszlo F ^a   Laszlo F A ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Adrenergic antagonist; Adrenergic regulation; Atenolol; Corynanthine; Neurohypophyseal tissue culture; Phentolamine; Pindolol; Propranolol; Vasopressin; Yohimbine

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; CORYNANTHINE; NORADRENALIN; PHENTOLAMINE; PINDOLOL; PROPRANOLOL; VASOPRESSIN; YOHIMBINE;

ADRENALIN RELEASE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTRINSIC SYMPATHOMIMETIC ACTIVITY; NEUROHYPOPHYSIS; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM; STATISTICAL ANALYSIS; TISSUE CULTURE; VASOPRESSIN RELEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; EPINEPHRINE; MALE; NOREPINEPHRINE; PHENTOLAMINE; PINDOLOL; PITUITARY GLAND, POSTERIOR; PROPRANOLOL; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2; TISSUE CULTURE TECHNIQUES; VASOPRESSINS; YOHIMBINE;

RATTUS;

EID: 44349184835     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.03.004     Document Type: Article

References (64)

1. Daniel A.R., and Lederis K. Release of neurohypophysial hormones in vitro. J Physiol 190 (1967) 171-187
2. Pearson D., Shainberg A., Osinchak J., and Sachs H. The hypothalamo-neurohypophysial complex in organ culture: morphologic and biochemical characteristics. Endocrinology 96 (1975) 982-993
3. László F.A., Gálfi M., Jójárt I., Vecsernyés M., Laczi F., and Maderschpach K. Neurohypophysis tissue culture as a model of hormonal activity of rat pituicytes. Proc 4th Int Conf Neurohypophysis, new aspects of morphology function and regulation (1989), Oxford Univ Press, Copenhagen 87-91
4. Janáky T., Szabo P., Kele Z., Balaspiri L., Varga C., Galfi M., Vecsernyes M., Gaspar L., Juhasz A., and Laszlo F.A. Identification of oxytocin and vasopressin from neurohypophyseal cell culture. Rapid Commun Mass Spectrom 12 (1998) 1765-1768
5. Boersma C.J., Sonnemans M.A., and Van Leeuwen F.W. Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe. Brain Res 611 (1993) 117-129
6. Pu L.P., Van Leeuwen F.W., Tracer H.L., Sonnemans M.A., and Loh Y.P. Localization of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation. Proc Natl Acad Sci U S A 92 (1995) 10653-10657
7. Hatton G.I., Perlmutter L.S., Salm A.K., and Tweedle C.D. Dynamic neuronal-glial interactions in hypothalamus and pituitary: implications for control of hormone synthesis and release. Peptides 5 Suppl 1 (1984) 121-138
8. Murphy D., Levy A., Lightman S., and Carter D. Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading. Proc Natl Acad Sci U S A 86 (1989) 9002-9005
9. Buijs R.M., Geffard M., Pool C.W., and Hoorneman E.M. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res 323 (1984) 65-72
10. Lindvall O., Bjorklund A., and Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res 306 (1984) 19-30
11. Falke N. Modulation of oxytocin and vasopressin release at the level of the neurohypophysis. Prog Neurobiol 36 (1991) 465-484
12. Reichlin S. Neuroendocrinology. In: Wilson J.D., Foster D.W., Kronenberg H.M., and Larsen P.R. (Eds). Textbook of endocrinology (1998) 165-248 Philadelphia
13. Kjaer A., Knigge U., Olsen L., Vilhardt H., and Warberg J. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response. Endocrinology 128 (1991) 103-110
14. Tuomisto L., Eriksson L., and Fyhrquist F. Vasopressin release by histamine in the conscious goat. Eur J Pharmacol 63 (1980) 15-24
15. Tuomisto L., Eriksson L., and Fyhrquist F. Plasma vasopressin levels after I.C.V. infusion of histamine agonists in the conscious goat. Agents Actions 14 (1984) 558-560
16. Melander T., Hokfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A., and Goldstein M. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 6 (1986) 3640-3654
17. Rokaeus A., Young III W.S., and Mezey E. Galanin coexists with vasopressin in the normal rat hypothalamus and galanin's synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci Lett 90 (1988) 45-50
18. Skofitsch G., Jacobowitz D.M., Amann R., and Lembeck F. Galanin and vasopressin coexist in the rat hypothalamo-neurohypophyseal system. Neuroendocrinology 49 (1989) 419-427
19. Leng G., Brown C.H., and Russell J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 57 (1999) 625-655
20. Stone J.D., Crofton J.T., and Share L. Sex differences in central adrenergic control of vasopressin release. Am J Physiol 257 (1989) R1040-R1045
21. Brooks D.P., Share L., and Crofton J.T. Central adrenergic control of vasopressin release. Neuroendocrinology 42 (1986) 416-420
22. Day T.A., Randle J.C., and Renaud L.P. Opposing alpha- and beta-adrenergic mechanisms mediate dose-dependent actions of noradrenaline on supraoptic vasopressin neurones in vivo. Brain Res 358 (1985) 171-179
23. Cole R.L., and Sawchenko P.E. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci 22 (2002) 959-969
24. Randle J.C., Bourque C.W., and Renaud L.P. Alpha 1-adrenergic receptor activation depolarizes rat supraoptic neurosecretory neurons in vitro. Am J Physiol 251 (1986) R569-R574
25. Yamashita H., Inenaga K., and Kannan H. Depolarizing effect of noradrenaline on neurons of the rat supraoptic nucleus in vitro. Brain Res 405 (1987) 348-352
26. Randle J.C., Mazurek M., Kneifel D., Dufresne J., and Renaud L.P. Alpha 1-adrenergic receptor activation releases vasopressin and oxytocin from perfused rat hypothalamic explants. Neurosci Lett 65 (1986) 219-223
27. Khanna S., Sibbald J.R., and Day T.A. Alpha 2-adrenoceptor modulation of A1 noradrenergic neuron input to supraoptic vasopressin cells. Brain Res 613 (1993) 164-167
28. Kimura T., Share L., Wang B.C., and Crofton J.T. The role of central adrenoreceptors in the control of vasopressin release and blood pressure. Endocrinology 108 (1981) 1829-1836
29. Kimura T., Shoji M., Iitake K., Ota K., Matsui K., and Yoshinaga K. The role of central alpha 1- and alpha 2-adrenoceptors in the regulation of vasopressin release and the cardiovascular system. Endocrinology 114 (1984) 1426-1432
30. Yamashita H., Inenaga K., and Dyball R.E. Thermal, osmotic and chemical modulation of neural activity in the paraventricular nucleus: in vitro studies. Brain Res Bull 20 (1988) 825-829
31. Kennedy P.G., Lisak R.P., and Raff M.C. Cell type-specific markers for human glial and neuronal cells in culture. Lab Invest 43 (1980) 342-351
32. Michler-Stuke A., and Bottenstein J.E. Proliferation of glial-derived cells in defined media. J Neurosci Res 7 (1982) 215-228
33. Huszti Z., Rimanoczy A., Juhasz A., and Magyar K. Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia 3 (1990) 159-168
34. Julesz J., Gálfi M., Molnár J., and Vecsernyés M. Central effects of tricyclic compounds on the endocrine system-an in vitro study. Prog Brain Res 91 (1992) 89-92
35. Galfi M., Janaky T., Toth R., Prohaszka G., Juhasz A., Varga C., and Laszlo F.A. Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Regul Pept 98 (2001) 49-54
36. Dogterom J., van Wimersma Greidanus T.B., and De Wied D. Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat. Am J Physiol 234 (1978) E463-E467
37. Laczi F., Ivanyi T., Julesz J., Janaky T., and Laszlo F.A. Plasma arginine-8-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus. Acta Endocrinol (Copenh) 113 (1986) 168-174
38. Hunter W.M., and Greenwood F.C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature 194 (1962) 495-496
39. Janáky T., Tóth G., Penke B., Kovács K., and László F.A. Iodination of peptide hormones and purification of iodinated peptides by HPLC. J Liq Chromatogr 5 (1982) 1499-1507
40. Dudas B., Semeniken K.R., and Merchenthaler I. Morphological substrate of the catecholaminergic input of the vasopressin neuronal system in humans. J Neuroendocrinol 18 (2006) 895-901
41. Knigge K.M., Hoffman G., Scott D.E., and Sladek Jr. J.R. Identification of catecholamine and luteinizing hormone-releasing hormone (LHRH)-containing neurons in primary cultures of dispersed cells of the basal hypothalamus. Brain Res 120 (1977) 393-405
42. Jirikowski G., Reisert I., and Pilgrim C. Neuropeptides in dissociated cultures of hypothalamus and septum: quantitation of immunoreactive neurons. Neuroscience 6 (1981) 1953-1960
43. Ansonoff M.A., and Etgen A.M. Evidence that oestradiol attenuates beta-adrenoceptor function in the hypothalamus of female rats by altering receptor phosphorylation and sequestration. J Neuroendocrinol 12 (2000) 1060-1066
44. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., and Fremeau Jr. R.T. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21 (1994) 133-149
45. Tohyama M., Wanaka A., Araki T., Betz H., and Malbon C.C. Localization of glycine and beta-adrenergic receptors in the rat brain. Arch Histol Cytol 52 Suppl (1989) 39-48
46. Acosta-Martinez M., Fiber J.M., Brown R.D., and Etgen A.M. Localization of alpha1B-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function. Neurochem Int 35 (1999) 383-391
47. Pascual J., del Arco C., Gonzalez A.M., and Pazos A. Quantitative light microscopic autoradiographic localization of alpha 2-adrenoceptors in the human brain. Brain Res 585 (1992) 116-127
48. Mohr E., Zhou A., Thorn N.A., and Richter D. Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe. FEBS Lett 263 (1990) 332-336
49. Tweedle C.D., and Hatton G.I. Morphological adaptability at neurosecretory axonal endings on the neurovascular contact zone of the rat neurohypophysis. Neuroscience 20 (1987) 241-246
50. Rhodes C.H., Morrell J.I., and Pfaff D.W. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol 198 (1981) 45-64
51. Swaab D.F., Nijveldt F., and Pool C.W. Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol 67 (1975) 461-462
52. Boersma C.J., and Van Leeuwen F.W. Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors. Neuroscience 62 (1994) 1003-1020
53. Galfi M., Balaspiri L., Toth R., Pavo I., Csajbok E., Laszlo F., Morschl E., Varga C., and Laszlo F.A. Inhibitory effect of galanin on dopamine induced increased oxytocin secretion in rat neurohypophyseal tissue cultures. Regul Pept 116 (2003) 35-41
54. Galfi M., Balaspiri L., Toth R., Pavo I., Laszlo F., Morschl E., Varga C., and Laszlo F.A. Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures. Regul Pept 110 (2002) 17-23
55. Galfi M., Radacs M., Juhasz A., Laszlo F., Molnar A., and Laszlo F.A. Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture. Regul Pept 127 (2005) 225-231
56. Radacs M., Galfi M., Juhasz A., Varga C., Molnar A., Laszlo F., and Laszlo F.A. Histamine-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultures. Regul Pept 134 (2006) 82-88
57. De Souza E.B., and Kuyatt B.L. Alpha 1-adrenergic receptors in the neural lobe of the rat pituitary: autoradiographic identification and localization. Endocrinology 120 (1987) 2227-2233
58. Brede M., Philipp M., Knaus A., Muthig V., and Hein L. alpha2-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models. Biol Cell 96 (2004) 343-348
59. Docherty J.R. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 361 (1998) 1-15
60. Hein L., and Kobilka B.K. Adrenergic receptors-from molecular structure to in vivo function. Trends Cardiovasc Med 7 (1997) 137-145
61. Zhong H., and Minneman K.P. Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375 (1999) 261-276
62. Heintzen M.P., and Strauer B.E. Peripheral vascular effects of beta-blockers. Eur Heart J 15 Suppl C (1994) 2-7
63. Lima J.J. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity. J Recept Signal Transduct Res 16 (1996) 357-372
64. Wesslau C., and Smith U. The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP. Biochem J 288 Pt 1 (1992) 41-46